Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,580 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

for
Pancreatic Cancer
Location: Duarte CA, St Louis MO, Birmingham AL, Cleveland OH
Sponsor: Varian, a Siemens Healthineers Company

Sex: All

Age: 18+

Code: NCT05764720

Recruiting

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Duarte CA, San Francisco CA, Denver CO, Houston TX,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05131022

Phase 1, Recruiting

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

for
Cutaneous Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04670874

Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

for
Mycosis Fungoides, Non-Hodgkin's Lymphoma
Location: Duarte CA, Palo Alto CA, Salt Lake City UT, Dallas TX,
Sponsor: Stanford University

Sex: All

Age: 0+

Code: NCT02848274

Recruiting

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

for
Lower Respiratory Tract Infection, Parainfluenza,
Location: Duarte CA, Sacramento CA, Seattle WA, Oklahoma City OK,
Sponsor: Ansun Biopharma, Inc.

Sex: All

Age: 0+

Code: NCT03808922

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

for
Metastatic Solid Tumor, Advanced Solid Tumor
Location: Duarte CA, Las Vegas NV, West Valley City UT,
Sponsor: Coherus Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06657144

Phase 1, Recruiting

Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer

for
Muscle Invasive Bladder Urothelial Carcinoma
Location: Duarte CA, Indianapolis IN, Philadelphia PA,
Sponsor: Matthew Galsky

Sex: All

Age: 18+

Code: NCT06809140

Phase 2, Recruiting

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT

for
Duchenne Muscular Dystrophy
Location: Loma Linda CA, Sacramento CA, Phoenix AZ,
Sponsor: Catalyst Pharmaceuticals, Inc.

Sex: Male

Age: 2+

Code: NCT06564974

Recruiting

Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06054776

Phase 2, Recruiting

Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study

for
Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study,
Location: Culver City CA
Sponsor: Imugene Limited

Sex: All

Age: 18 - 70+

Code: NCT05822427

Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

for
Relapsed/Refractory Systemic Light Chain Amyloidosis
Location: Duarte CA, Denver CO, Houston TX, Nashville TN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06292780

Phase 1, Phase 2, Recruiting

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

for
Solid Tumor, Adult
Location: Duarte CA, San Diego CA, San Francisco CA, Seattle WA,
Sponsor: Corbus Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06265727

Phase 1, Phase 2, Recruiting

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

for
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations,
Location: Duarte CA, Las Vegas NV, Houston TX, Milwaukee WI,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05967689

Phase 2, Recruiting

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia

for
Chronic Myeloid Leukemia,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT06229860

Recruiting

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

for
Relapsed/Refractory Non-Hodgkin Lymphoma
Location: Duarte CA, Phoenix AZ, Rochester MN, Tampa FL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06090539

Phase 1, Phase 2, Recruiting

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

for
Neoplasms
Location: Duarte CA, Aurora CO, Seattle WA, Calgary, Houston TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06150157

Phase 1, Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

for
Leukemia, Myeloid, Chronic, Myeloid Leukemia,
Location: Duarte CA, Seattle WA, Houston TX, Birmingham AL,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT04260022

Phase 1, Recruiting

A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma

for
Solid Tumor, Adult, Lymphoma
Location: Duarte CA, Houston TX
Sponsor: Cyclacel Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT04983810

Phase 1, Phase 2, Recruiting

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

for
Recurrent Head and Neck Squamous Cell Carcinoma
Location: Duarte CA, Sioux Falls SD, Houston TX, Tampa FL,
Sponsor: Rakuten Medical, Inc.

Sex: All

Age: 18+

Code: NCT06699212

Phase 3, Recruiting

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

for
Intracerebral Hemorrhage, Stroke, Hypertension
Location: Irvine CA, Lancaster CA, Palo Alto CA, San Antonio TX,
Sponsor: Zeenat Qureshi Stroke Institute

Sex: All

Age: 18 - 70+

Code: NCT06402968

Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles